BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4356930)

  • 1. Epstein-Barr virus: stimulation by 5'-iododeoxyuridine or 5'-bromodeoxyuridine in human lymphoblastoid cells from a rhabdomyosarcoma.
    Houts GE; Szakacs MR; Szakacs JE
    Ann Clin Lab Sci; 1973; 3(6):429-33. PubMed ID: 4356930
    [No Abstract]   [Full Text] [Related]  

  • 2. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
    Prachová K
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of Epstein-Barr virus-related membrane antigens by 5-iododeoxyuridine in non-producer human lymphoblastoid cells.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1973 Nov; 246(151):70-2. PubMed ID: 4357308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Induction of a viral expression by 5-bromodeoxyuridine (BUdR) and 5-iododeoxyuridine (IUdR), in cell lines derived from Burkitt's lymphoma and rhinopharyngeal cancers].
    Didier-Fichet ML; de Thé G
    C R Acad Hebd Seances Acad Sci D; 1972 Apr; 274(17):2549-52. PubMed ID: 4624837
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
    Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
    Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):78-82. PubMed ID: 4550511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.
    Derge JG; Martos LM; Tagamets MA; Chang SY; Chakrabarty M
    Nat New Biol; 1973 Aug; 244(137):214-7. PubMed ID: 4353682
    [No Abstract]   [Full Text] [Related]  

  • 10. Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.
    Lowy DR; Rowe WP; Teich N; Hartley JW
    Science; 1971 Oct; 174(4005):155-6. PubMed ID: 4330367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-Iododeoxyuridine.
    Sugawara K; Osato T
    Nat New Biol; 1973 Nov; 246(151):72-3. PubMed ID: 4357309
    [No Abstract]   [Full Text] [Related]  

  • 13. Increase of Epstein-Barr-virus-positive cells in EB3 cultures after treatment with cis-dichloro-diammine-platinum.
    Vonka V; Kutinová L; Drobník J; Bräuerová J
    J Natl Cancer Inst; 1972 May; 48(5):1277-81. PubMed ID: 4337904
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural effects of thymidine analogs in melanosomes and virus activation in cloned hamster melanoma cells in culture.
    Epstein WL; Fukuyama K; Drake TE
    Yale J Biol Med; 1973 Dec; 46(5):471-81. PubMed ID: 4798393
    [No Abstract]   [Full Text] [Related]  

  • 17. Distamycin A inhibition of Epstein-Barr virus replication in arginine-deprived Burkitt lymphoblasts.
    Becker Y; Weinber A
    Isr J Med Sci; 1972 Jan; 8(1):75-8. PubMed ID: 4337391
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-iododeoxyuridine potentiation of the replication in vitro of several unrelated RNA and DNA viruses.
    Green JA; Baron S
    Science; 1975 Dec; 190(4219):1099-101. PubMed ID: 1188388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
    Ito Y; Kishishita M; Yanase S
    Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.